Fedora Pharmaceuticals Inc. research brief

CIK 1576423 Copy CIK

Generated Nov. 10, 2026, 4:15 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: EDMONTON A0. Reported legal jurisdiction: ALBERTA, CANADA. These do not establish investor residence or where funds were deployed.

• June 6, 2025 · D · 0001576423-25-000004 · Source evidence

  Reported offering amount: 7239326 USD. Reported amount sold: 895076 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Fedora Pharmaceuticals Inc. research brief,” CIK 1576423, retrieved Nov. 10, 2026, 4:15 p.m.. Cite the specific accessions used. No amounts have been summed.